gliotem TEMOZOLOMIDE

Introduction to gliotem

Gliotem is a medication available in tablet form, primarily used to treat certain aggressive brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. Gliotem works by targeting cancer cells in the brain.

Composition of gliotem

Gliotem contains the active ingredient Temozolomide, which is an alkylating agent. This compound interferes with the DNA of cancer cells, preventing them from growing and dividing.

Uses of gliotem

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of gliotem

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: low blood cell counts, increased risk of infection

Precautions of gliotem

Patients should be cautious as gliotem can lower blood cell counts, increasing infection risk. It is not recommended during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using it.

How to Take gliotem

Gliotem is taken orally, usually as a tablet. The typical starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor's advice for the correct dosage and administration.

Conclusion of gliotem

Gliotem, containing the active ingredient Temozolomide, is a part of the alkylating agents therapeutic class. It is primarily used to treat aggressive brain tumors like glioblastoma multiforme and anaplastic astrocytoma. Manufactured with precision, gliotem offers a targeted approach to cancer treatment. Always consult with a healthcare professional for personalized advice and guidance on using gliotem effectively.